ETHEMA HEALTH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.00055 USD | -8.33% |
|
0.00% | +100.00% |
| 11/06 | Ethema Health Insider Bought Shares Worth $1,457,200, According to a Recent SEC Filing | MT |
| 31/05 | Ethema Health Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 48.21L 40Cr | Sales 2023 | 53.45L 45Cr | Capitalization | 11.19L 9.33Cr |
|---|---|---|---|---|---|
| Net income 2022 | - 0 | Net income 2023 | 10L 8.34Cr | EV / Sales 2022 | 2.65 x |
| Net Debt 2022 | 1.13Cr 94Cr | Net Debt 2023 | 1.45Cr 121.07Cr | EV / Sales 2023 | 2.92 x |
| P/E ratio 2022 |
10.8
x | P/E ratio 2023 |
0.99
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.3% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -8.33% | ||
| Current month | +50.00% | ||
| 1 month | +50.00% | ||
| 3 months | +50.00% | ||
| 6 months | +50.00% | ||
| Current year | +100.00% |
1 week
0.00
0.00
1 month
0.000.00
Current year
0.000.00
1 year
0.000.00
3 years
0.000.00
5 years
0.000.07
10 years
0.000.15
| Managers | Title | Age | Since |
|---|---|---|---|
Shawn Leon
CEO | Chief Executive Officer | 64 | 01/10/01 |
Anita Teslak
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shawn Leon
CEO | Chief Executive Officer | 64 | 01/10/01 |
Gerald Miller
BRD | Director/Board Member | 66 | 02/15/02 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/24/17 | 0.00055 | -8.33% | 13,014,398 |
| 14/24/14 | 0.0006 | +20.00% | 10,297,523 |
| 13/24/13 | 0.0005 | 0.00% | 14,351,132 |
| 12/24/12 | 0.0005 | -28.57% | 25,969,054 |
| 11/24/11 | 0.0007 | +27.27% | 91,797,224 |
Delayed Quote OTC Markets, June 18, 2024 at 01:24 am IST
More quotes
Ethema Health Corporation, together with its subsidiaries, operates in the behavioral healthcare space specifically in the treatment of substance-use disorders. The Company offers rehabilitation services in West Palm Beach, Florida. By working with scientists, doctors and researchers, the Company strives to develop better assessment and treatment modalities for the industry. The Company focuses on developing programs and techniques for North America.
| 1st Jan change | Capi. | |
|---|---|---|
| +100.00% | 20.51L | |
| +23.94% | 8.79TCr | |
| -22.63% | 7.67TCr | |
| +3.24% | 2.69TCr | |
| +4.10% | 1.78TCr | |
| -0.62% | 1.52TCr | |
| +76.28% | 1.36TCr | |
| +81.13% | 1.34TCr | |
| -24.56% | 1.3TCr | |
| +24.51% | 1.27TCr |
- Stock Market
- Equities
- GRST Stock
